LFST — Lifestance Health Income Statement
0.000.00%
Last trade - 00:00- $2.54bn
- $2.67bn
- $1.25bn
- 71
- 45
- 80
- 72
Annual income statement for Lifestance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 377 | 668 | 860 | 1,056 | 1,251 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 399 | 972 | 1,082 | 1,245 | 1,283 |
| Operating Profit | -21.7 | -305 | -222 | -189 | -32.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -44.4 | -333 | -233 | -207 | -57.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -38.1 | -307 | -216 | -186 | -57.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -38.1 | -307 | -216 | -186 | -57.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -311 | -344 | -216 | -186 | -57.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.769 | -0.973 | -0.573 | -0.386 | -0.144 |
| Dividends per Share |